After two years of recalibration, venture capital valuations have returned to something the market hasn’t seen in a while: historical norms. The distortion of 2021–2022 — characterized by outsized step-ups, inflated late-stage pricing, and compressed diligence cycles — has largely worked its way through the system.
Step-ups between rounds have normalized. Flat and down rounds have reset expectations. IPO pricing has realigned private marks with public discipline. For founders and investors heading into 2026, this shift is not a warning sign — it is a stabilizing force.
In rational markets, clarity replaces momentum. And clarity creates opportunity.
Step-Ups Are Back Within Historical Ranges
During the peak cycle, valuation step-ups between rounds often exceeded what underlying fundamentals justified. That dynamic has reversed. Median increases across Series A, B, and later stages have settled back toward long-term historical ranges.
This matters because step-ups drive both founder dilution and return math. When pricing reflects realistic growth assumptions, future rounds become more predictable — and exits less dependent on aggressive multiple expansion.
A stable step-up environment reduces the risk of punitive resets later. It also restores confidence for LPs underwriting long-duration venture returns.
Flat Rounds Reflect Discipline, Not Distress
A meaningful share of venture rounds over the past year have been flat or down relative to prior valuations. That statistic, viewed in isolation, can sound concerning. In context, it reflects recalibration.
The most aggressive pandemic-era marks have largely been corrected. Companies that last raised at peak-cycle pricing have either reset or absorbed slower growth expectations. Today’s pricing is more closely aligned with revenue reality, cost of capital, and exit math.
A flat round in 2026 is often a sign that expectations are grounded — not that a company is failing.
Public Markets Are Reinforcing Private Discipline
Private pricing does not exist in isolation. Public market listings in 2025 frequently priced at or below the last private round. That dynamic has filtered backward into venture underwriting.
When IPOs no longer guarantee valuation expansion, private investors adjust accordingly. The result is a market where growth still commands premium pricing — but only when supported by fundamentals.
This alignment between public and private markets is healthy. It lowers the probability of late-stage valuation shocks and increases confidence in exit planning.
Returns Are Stabilizing
After the volatility of 2022–2023, venture performance has begun to stabilize. Short-term return indicators have improved, and distribution yield has shown modest recovery.
This is not a return to peak-cycle exuberance. It is a move back toward normalized performance patterns — where returns are driven by company execution rather than multiple expansion.
For disciplined founders and investors, that shift is constructive.
Why This Is a Constructive Environment to Raise
When markets are distorted, timing dominates. When markets are rational, execution dominates.
Heading into 2026, founders raising capital face a clearer environment:
- Pricing expectations are grounded
- Step-ups are predictable
- Exit math is realistic
- Capital is selective but available
A normalized market does not guarantee easy fundraising. It does, however, reduce volatility and improve signal quality. Companies that demonstrate traction, capital efficiency, and differentiated positioning can raise into a system that rewards clarity rather than hype.
In other words, this is not a market that punishes ambition. It is a market that rewards preparation.
Conclusion
Venture valuations are no longer inflated — and they are no longer collapsing. They are normal. That normalization restores credibility to pricing, discipline to underwriting, and realism to exit assumptions.
For founders, this is not a moment to wait for exuberance to return. It is a moment to raise thoughtfully, with the right structure, the right partners, and a valuation that supports durable growth. In rational markets, preparation matters more than timing — and execution separates outcomes.
About Fidelman & Company
Fidelman & Company is a boutique investment bank advising high-growth technology companies, emerging managers, and institutional investors on venture capital fundraising, strategic transactions, and liquidity solutions. The firm specializes in Series A and growth-stage capital, secondary advisory, and founder-focused outcomes across the global startup ecosystem. With deep expertise in venture capital markets and access to leading LPs, Fidelman & Company supports clients navigating today’s evolving fundraising landscape.
Planning a raise in early 2026? Contact us to help align timing, materials, and outreach with what’s working now.
